Accelovance and the Midwest Melanoma Partnership (MMP) have a strategic agreement to facilitate clinical trial research and development. The focus of MMP is to "facilitate the sharing of ideas, clinical trials and resources in an effort to improve the diagnosis, treatment and long-term care of melanoma patients." Through this strategic relationship we are able to provide access to the top investigative sites and medical professionals in the US working in the area of melanoma. Specifically, this relationship entails:
For more information on Midwest Melanoma Partnership, please visit their website.
Dr. Harish Dave, board certified oncologist, has been involved in over 100 clinical trials. He leads our Medical Affairs & Drug Safety group where he leverages over 25 years' experience gained from academia, as a principal investigator, and industry professional. Dr. Dave provides input and development within our Oncology consulting team along with Jamie Oliver, Chief Scientific Officer.